Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Kohlberg Kravis Roberts (KKR) has agreed to acquire Capsugel business of Pfizer for around $2.375bn in cash, under an agreement signed between the companies.
Subscribe to our email newsletter
Capugel is a provider of hard capsules and an innovator in drug delivery systems for the pharmaceutical, OTC and health and nutrition industries.
Folllowing the transaction, all Pfizer colleagues currently dedicated to this business will be transferred to Capsugel, which will be under the leadership of Capsugel president and general manager Guido Driesen upon the completion of the transaction.
Driesen said the transaction is an endorsement of Capsugel’s consistent success to date and its potential for future growth with KKR.
The KKR and Pfizer expect to complete the transaction in the third quarter of 2011, assuming the receipt of the required regulatory clearances and satisfaction of other closing conditions.